These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 16149047
1. Nutritional therapy improves function and complements corticosteroid intervention in mdx mice. Payne ET, Yasuda N, Bourgeois JM, Devries MC, Rodriguez MC, Yousuf J, Tarnopolsky MA. Muscle Nerve; 2006 Jan; 33(1):66-77. PubMed ID: 16149047 [Abstract] [Full Text] [Related]
3. [Effect of long-term administration of prednisolone on serum creatine kinase and muscle pathology of mdx mouse]. Takagi A, Watanabe T, Kojima S, Endo Y. Rinsho Shinkeigaku; 1998 Aug; 38(8):724-8. PubMed ID: 9916517 [Abstract] [Full Text] [Related]
4. Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout. Golumbek PT, Keeling RM, Connolly AM. Neuromuscul Disord; 2007 May; 17(5):376-84. PubMed ID: 17452104 [Abstract] [Full Text] [Related]
5. l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice. Mok E, Constantin B, Favreau F, Neveux N, Magaud C, Delwail A, Hankard R. Pediatr Res; 2008 Mar; 63(3):268-73. PubMed ID: 18287965 [Abstract] [Full Text] [Related]
6. Motor performance of young dystrophic mdx mice treated with long-circulating prednisolone liposomes. Weller C, Zschüntzsch J, Makosch G, Metselaar JM, Klinker F, Klinge L, Liebetanz D, Schmidt J. J Neurosci Res; 2012 May; 90(5):1067-77. PubMed ID: 22253213 [Abstract] [Full Text] [Related]
7. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Ito K, Kimura S, Ozasa S, Matsukura M, Ikezawa M, Yoshioka K, Ueno H, Suzuki M, Araki K, Yamamura K, Miwa T, Dickson G, Thomas GD, Miike T. Hum Mol Genet; 2006 Jul 15; 15(14):2266-75. PubMed ID: 16777842 [Abstract] [Full Text] [Related]
8. [Effect of prednisolone on apoptosis and cellular infiltration in mdx mouse muscle]. Kojima S, Takagi A, Watanabe T. Rinsho Shinkeigaku; 1999 Nov 15; 39(11):1109-13. PubMed ID: 10689931 [Abstract] [Full Text] [Related]
9. A review of nutrition in Duchenne muscular dystrophy. Davidson ZE, Truby H. J Hum Nutr Diet; 2009 Oct 15; 22(5):383-93. PubMed ID: 19743977 [Abstract] [Full Text] [Related]
10. Effects of a CRF2R agonist and exercise on mdx and wildtype skeletal muscle. Hall JE, Kaczor JJ, Hettinga BP, Isfort RJ, Tarnopolsky MA. Muscle Nerve; 2007 Sep 15; 36(3):336-41. PubMed ID: 17503504 [Abstract] [Full Text] [Related]
11. Treatment with inhibitors of the NF-kappaB pathway improves whole body tension development in the mdx mouse. Siegel AL, Bledsoe C, Lavin J, Gatti F, Berge J, Millman G, Turin E, Winders WT, Rutter J, Palmeiri B, Carlson CG. Neuromuscul Disord; 2009 Feb 15; 19(2):131-9. PubMed ID: 19054675 [Abstract] [Full Text] [Related]
12. Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice. Bizario JC, Cerri DG, Rodrigues LC, Oliveira GL, Nomizo A, de Araujo DD, Fukuhara PS, Ribeiro JC, de Castro FA, Costa MC. J Neuroimmunol; 2009 Jul 25; 212(1-2):93-101. PubMed ID: 19508953 [Abstract] [Full Text] [Related]
13. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment. Radley HG, Davies MJ, Grounds MD. Neuromuscul Disord; 2008 Mar 25; 18(3):227-38. PubMed ID: 18207402 [Abstract] [Full Text] [Related]
14. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Messina S, Bitto A, Aguennouz M, Minutoli L, Monici MC, Altavilla D, Squadrito F, Vita G. Exp Neurol; 2006 Mar 25; 198(1):234-41. PubMed ID: 16410003 [Abstract] [Full Text] [Related]